Drug and Device Shortages

Below is a list of current and anticipated ophthalmic drug and device shortages. This table is generated from Health Canada and is intended for use by practicing ophthalmologists. Drugs that have been out of production or unavailable for more than 12 months are not included in this table.

The table is updated daily.

SHORTAGE: C3F8

Cyclopentolate 1% Update

Health Canada Consultation

Biosimilars Update

Submission to Health Canada’s Consultation on Improving Access to Drugs and Other Health Products

Ophthalmic Essential Medication List for Canada

Last Updated: 2026-01-06 00:02:52

Drug NameDrug StatusLast UpdatedDINTypeAnticipated Start DateEstimated End DateActual Start DateActual End DateShortage Reason
TEVA-PREDNISOLONEMarketed2025-05-1500700401Shortage2026-01-102025-12-17Disruption of the manufacture of the drug.
APO-TIMOPMarketed2025-05-1500755834Shortage2026-06-262025-01-14Disruption of the manufacture of the drug.
PDP-ERYTHROMYCINMarketed2025-05-1501912755Shortage2025-07-23Shortage of an active ingredient.
MIOCHOL-EMarketed2025-12-0302133326Shortage2025-12-042026-03-132025-12-04Disruption of the manufacture of the drug.
OCUFLOXMarketed2025-05-1502143291Shortage2026-01-162025-08-12Disruption of the manufacture of the drug.
DIOFLUOR STRIPSMarketed2025-05-1502160773Shortage2020-12-012025-12-302021-03-22Disruption of the manufacture of the drug.
SANDOZ TIMOLOLMarketed2025-05-1502166712Shortage2025-12-122025-10-06Demand increase for the drug.
SANDOZ TIMOLOLMarketed2025-05-1502166720Shortage2025-12-122025-10-20Disruption of the manufacture of the drug.
SANDOZ TIMOLOLMarketed2025-05-1502166720Shortage2025-09-122025-08-11Disruption of the manufacture of the drug.
SANDOZ TIMOLOLMarketed2025-05-1502166720Shortage2025-09-192025-07-14Disruption of the manufacture of the drug.
TIMOLOL MALEATE-EXMarketed2025-05-1502242275Shortage2027-06-252024-05-13Disruption of the manufacture of the drug.
TIMOLOL MALEATE-EXMarketed2025-05-1502242276Shortage2027-06-252025-11-17Disruption of the manufacture of the drug.
VISUDYNEMarketed2025-05-1502242367Shortage2025-08-272026-06-30Disruption of the manufacture of the drug.
KETOROLACMarketed2025-05-1502245821Shortage2025-12-302026-06-26Disruption of the manufacture of the drug.
KETOROLACMarketed2025-05-1502245821Shortage2025-10-072026-01-26Disruption of the manufacture of the drug.
COMBIGANMarketed2025-05-1502248347Shortage2026-01-302025-09-22Demand increase for the drug.
TEVA-LATANOPROSTMarketed2025-12-0302254786Shortage2024-05-08Disruption of the manufacture of the drug.
ZYMARMarketed2025-05-1502257270Shortage2026-01-162025-11-11Disruption of the manufacture of the drug.
DUOTRAV PQMarketed2025-05-1502278251Shortage2026-01-192026-02-12Demand increase for the drug.
SANDOZ BRIMONIDINEMarketed2025-05-1502305429Shortage2026-01-162025-11-17Disruption of the manufacture of the drug.
APO-GATIFLOXACINMarketed2025-05-1502327260Shortage2026-06-262025-08-12Disruption of the manufacture of the drug.
SANDOZ DORZOLAMIDE/TIMOLOLMarketed2025-05-1502344351Shortage2026-01-162025-11-03Disruption of the manufacture of the drug.
SANDOZ LATANOPROSTMarketed2025-05-1502367335Shortage2025-11-142025-10-03Disruption of the manufacture of the drug.
APO-MOXIFLOXACINMarketed2025-05-1502406373Shortage2026-04-102025-12-02Disruption of the manufacture of the drug.
SANDOZ TRAVOPROSTMarketed2025-05-1502413167Shortage2026-01-092025-12-19Disruption of the manufacture of the drug.
APO-TRAVOPROST-TIMOP PQMarketed2025-05-1502415305Shortage2026-02-062025-10-08Disruption of the manufacture of the drug.
TEVA-LATANOPROST-TIMOLOLMarketed2025-05-1502436256Shortage2021-08-27Disruption of the manufacture of the drug.
JAMP-TIMOLOLMarketed2025-05-1502447800Shortage2026-02-122025-03-03Demand increase for the drug.